THAILAND PIC/S ACCESSION: JOURNEY TOWARDS THE 49 TH PIC/S PARTICIPATING AUTHORITY. Suchart Chongprasert, Ph.D. Food and Drug Administration Thailand

Similar documents
Current Status and Challenges of Bilateral/Multilateral Meetings

EU, USA and Japan (II) Reports from Regulators on Exchange Assignments

CDER s Office of Pharmaceutical Quality (OPQ): Delivering on the 21 st Century Quality Goals

ASEAN Regulatory Harmonisation and Approval Process

Swissmedic, Swiss Agency for Therapeutic Products

Software as a Medical Device (SaMD)

the SPD company Dr Clive Simon, Principal, The SPD Company.

Governance at Dai-ichi Life Group

CMC Topics and PMDA s activities Yoshihiro Matsuda, Ph.D.

Second APEC Ministers' Conference on Regional Science & Technology Cooperation (Seoul, Korea, Nov 13-14, 1996) JOINT COMMUNIQUÉ

ISPE THAILAND 15 TH ANNIVERSARY ANNUAL MEETING 2018 JULY 16 TH 18 TH, 2018 AMBASSADOR HOTEL, BANGKOK THAILAND

PROJECT DOCUMENT ACHIEVEMENTS FOR YEAR 2015 AND PROPOSED ACTIVITY FOR YEAR 2016

Inter-Association Task Force

Brazilian industry s activities for international convergence. Walker Lahmann Director of External Trade at ABIFINA Executive Director at Eurofarma

Overview on Medicines Regulation: regulatory cooperation and harmonization in focus

ICH Q7 - API. Presented by Ashley Isbel 4 July, 2016

Gary Condran Associate Director Bureau of Pharmaceutical Sciences, Therapeutic Product Directorate, HPFB, Health Canada

Progress in FDA s Drug Product Quality Initiative. Janet Woodcock, M.D. November 13, 2003

Quality Risk Management

LSIF Convenor s Summary Report to CTI

WHO Regulatory Systems Strengthening Program

The 21 st APEC Small and Medium Enterprises Ministerial Meeting Joint Ministerial Statement. Nanjing, China September 5, 2014

VENUE. 2 DAY WORKSHOP On FDA Penalties for Regulatory Non-Compliance in the Pharmaceuticals Industry in Review , JAN San Diego CA

CER-ASEAN Integration Partnership Forum. CER-ASEAN participation in global frameworks for international recognition and harmonisation of measurement

EDQM COUNCIL OF EUROPE CONFERENCE CERTIFICATION PROCEDURE : 20 YEARS OF EXPERIENCE March EDQM, Strasbourg, France ABSTRACTS

FDA Centers of Excellence in Regulatory and Information Sciences

ICH Q10 Pharmaceutical Quality System

Confidence Building in Peaceful Use of Nuclear Energy Transparency and Human Resource Development in Asia Pacific Region

Implementing Quality Systems

Trans-Pacific Partnership Lost Important IP Provisions

Quality Regulation under Revised Pharmaceutical Affair Law

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

Claus Mortensen, Medicines Inspector. Danish Medicines Agency. Member of the EMEA PAT team

Overview and Version 3.1.0

EMBARGOED TILL DELIVERY

Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?

FDA s Evolving Approach to Pharmaceutical Quality

Standing Committee on the Law of Patents

Office of Pharmaceutical Quality: Why, What, and How?

Management Oversight and Control: How to Ensure Compliance and Limit Liability

NZFSA Policy on Food Safety Equivalence:

Guidance for Industry

ICH Q-IWG Integrated Training Programme

New ITS Project Proposed INOGATE Work Program for Sustainable Energy (Component C)

Towards malaria elimination: ADB-supported work at Myanmar FDA

The value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016

Global GMP Harmonisation A Japanese Perspective

SME Internationalization and Measurement (Presentation)

Masanobu UEDA International Affairs Division Japan Patent Office

Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency

Emerged! Professional Intermediate Study Coordinator Training Workshop

MA/INS/GMP/735037/2014 Annex 1 of the GMP Guidelines on Good Manufacturing Practice - Manufacture of Sterile Medicinal Products

Recreation Facility Hours

Q8 and Q8 annex An industry Perspective

APSEC President s Report

SMART DUBAI INSPIRING NEW REALITIES

JUST SCRATCHING THE SERVICE

TECHNOLOGY VISION 2017 IN 60 SECONDS

Appendix-1. Project Design Matrix (PDM)

Intellectual Property Corporation of Malaysia

IGDRP Mission, Scope, How it works

MEDIA KIT 2018 MEDIA KIT 2018 DELIVERING AN AUDIENCE OF ENGAGED PROFESSIONAL AND EMERGING PHOTOGRAPHERS LEAH KENNEDY

The Industrial Strategy Challenge Fund

THE UNIVERSITY OF MELBOURNE ARCHIVES. Fraser, John Malcolm (Rt Hon.)

CBD Request to WIPO on the Interrelation of Access to Genetic Resources and Disclosure Requirements

TBT Provisions in RTAs: Do they go beyond the TBT Agreement?

China: Managing the IP Lifecycle 2018/2019

Preparation of requirements. Part I Notification principles and time schedule

A GUIDE TO EFFECTIVE COMMUNICATION WITH MAIN CONTRACTORS

Access to Technology in the Post-2015 Development Agenda. Alessandra Casazza Policy Advisor UNDP Asia-Pacific Regional Center

Privacy Policy SOP-031

Challenges of Implementation of ICH Q 8

Session III: How Current Offices are Promoting the Madrid System to Maximize its Potential by its Users

Progress on the Implementation of Eleven Priority Sectors (as of 6 July 2005)

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Should privacy impact assessments be mandatory? David Wright Trilateral Research & Consulting 17 Sept 2009

ASEAN MINERALS COOPERATION ACTION PLAN Dynamic Mineral Sector Initiatives for a Prosperous ASEAN

Technology Transfer as the Process of Pharmaceutical Quality System: Modelling Technology Transfer as a Process Strategy

Office of Pharmaceutical Quality Key Quality Initiatives

GMDN An Introduction. Mark Wasmuth CEO, GMDN Agency

Announcement of Korea Research Fellowship (KRF) for Postdoctoral Researchers (1st round in 2018)

Value Paper. Are you PAT and QbD Ready? Get up to speed

Local Business Development Forum November 2010 Brunei Professor Tan Kim Song Singapore Management University

IEEE Working Group Process, Status, and Technology Session #33: Seoul, Korea 30 August 2004

High-Power Series Pneumatic Series Hydraulic Hydraulic Series Valve / Coupler Expansion Locating Pin Hydraulic Unit Manual Operation Accessories

Bi- and multilateral S&T Programmes of SEA countries - THAILAND

MEDICAL TECHNOLOGY REGULATION. Understanding Where We Have Been and Where We Are Going with Harmonization

Quality assurance in the supply chain for pharmaceuticals from the WHO perspective

Fourth Annual Multi-Stakeholder Forum on Science, Technology and Innovation for the Sustainable Development Goals

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

The Second Health Information Technology Summit

RTÉ Player. July 2014 Review

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH. Notice to Industry Letters

EU-ASEAN Forum on Food Safety ASEAN Food Safety Policy *Tentative Programme (as at 2 nd November 2016)

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

EU GMP Evolution or Revolution Scope and drivers for EU GMP changes. August Gordon Farquharson

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

MEMORANDUM OF UNDERSTANDING On Cooperation Among APEC Financial Institutions Dealing with SMEs

PDA 71 Years of Connecting People, Science and Regulation

QUALITY: BRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW VETERINARY DRUG SUBSTANCES AND MEDICINAL PRODUCTS

Transcription:

THAILAND PIC/S ACCESSION: JOURNEY TOWARDS THE 49 TH PIC/S PARTICIPATING AUTHORITY 20 Mar 2015 1 Aug 2016 Suchart Chongprasert, Ph.D. Food and Drug Administration Thailand

CONTENTS Historical Evolution of GMP Inspections in Thailand Journey Towards PIC/S membership On Becoming PIC/S PA: Key Lesson Learned Challenges Ahead Connecting Pharmaceutical Knowledge ispe.org

Historical Evolution of GMP Inspections in Thailand 1986 Encourage Modern Medicine manufacturers (MM) to implement WHO GMP on voluntary basis 2003 1 st Implementation of GMP inspections for MM under Public Health Ministerial Notification following WHO GMP 1992 Oct 2012 Full Implementation of GMP inspections for MM under Public Health Ministerial Notification following PIC/S guideline PE009-09 3

Historical Evolution of GMP Inspection in Thailand (Cont.) Jun 2013 Applied for ASEAN Listed Inspection Service to prove for PIC/S GMP Conformance via Panel of Experts (Limited scope for Finished MM Pharmaceutical Dosage Forms only) Feb 2014 1st Implementation of GMP inspections for Traditional Medicine manufacturers (TM) under Public Health Ministerial Notification following PIC/S guideline PE009-09 Mar 2015 Acceding to become 4 th ASEAN Listed Inspection Service 4

Historical Evolution of GMP Inspection in Thailand (Cont.) Mar 2015 Mar 2016 May 2016 5 Jul 2016 1 Aug 2016 Official submission of application through PIC/S accession procedure PIC/S On-site assessment New Public Health Ministerial Notification to Implement PIC/S GMP Guides PE009-12 PIC/S Committee invited Thai FDA to join the scheme as PIC/S 49 th Participating Authority (PA) Officially became 49 th PIC/S s PA 5

24 Feb 2006 May 2007 1 st Round Application February 2006-2012 Submission of application Paper Assessment 21-25 Jan 2008 On-site Assessment based on 89 indicators Findings: 29 deficiencies Critical deficiencies =5 Major deficiencies =18 Minor deficiencies = 6 31 Jul 2008 28 Jan 2009 1 Oct 2009 28 Feb 2012 Feb 2012 Submission of CAPA Submission of CAPA Submission of progress report Submission of progress report Termination of application

PIC/S Assessment Team: 1 st Application PIC/S Assessment Team Affiliation Mr. Jacques Morénas, Rapporteur Ms. Kadariah Mohd Ali, Co-rapporteur Mr. Boon Meow Hoe, Co-rapporteur Mr. Paul Sexton, Co-rapporteur Mr. André Kovacs, Co-rapporteur AFSSAPS/France NPCB / Malaysia HSA / Singapore IMB / Ireland PIC/S Secretariat

2 nd Round Application 20 March 2015 PIC/S Paper Assessment Connecting Pharmaceutical Knowledge ispe.org

PIC/S Assessment Team: 2 nd Round PIC/S Assessment Team Affiliation Mr. Jacques Morénas, Rapporteur Mr. Boon Meow Hoe, Co-rapporteur Ms. Gaye Camm, Co-rapporteur Ms. Shanti Marlina, Co-rapporteur AFSSAPS/France HSA/ Singapore TGA/ Australia NADFC/ Indonesia

PIC/S On-site Assessment Opening Meeting 14 March 2016 Connecting Pharmaceutical Knowledge ispe.org

PIC/S On-site Assessment Closing Meeting: 18 March 2016 Connecting Pharmaceutical Knowledge ispe.org

Cheerful Group Picture Connecting Pharmaceutical Knowledge ispe.org

Outcome of On-site assessment PIC/S requirements (78 indicators) Fully fulfilled Fully fulfilled with condition Partially fulfilled 73 indicators 3 indicators 2 indicators

Indicator # Outcome of On-site assessment PIC/S requirements Fully fulfilled with condition Partially fulfilled 11 X 29 X when implemented 69 X subject to receiving new SOP Recall and rapid alert system 73 X subject to receiving new QM 76 X

Journey towards PIC/S Membership

Journey towards PIC/S Membership (cont.)

PIC/S Accession Letter of Thai FDA

Journey towards PIC/S Membership Connecting Pharmaceutical Knowledge ispe.org

On becoming PIC/S PA: Key Lessons Learned Political Will & Commitment from Senior Management Quality System in Place Determination of Team Thai FDA

Challenge ahead : Domestic Continued Political Will and Commitment from Senior Management Expanded Effective and Efficient Desktop GMP Inspection for Overseas Manufacturers Timely response to a rapidly changing regulatory environment driven by both PIC/S and advanced regulatory authorities 20

Challenges ahead : International On-site GMP Inspection Program for Overseas Manufacturers Team up with other regulatory authorities Shared GMP Inspection report? Joint Inspection Program? Active Engagement with PIC/S Family Business 21

Along this journey, we do not seek for perfectionism, but continuous improvement that keeps us abreast with the world. Connecting Pharmaceutical Knowledge ispe.org 22

ACKNOWLEDGEMENT Mrs. Prapassorn Thanaphollert Miss Sansanee Manchanda Connecting Pharmaceutical Knowledge ispe.org